Monte Carlo modeling of a commercial machine and experimental setup for FLASH‐minibeam irradiations with electrons
Medical Physics · 2025
DOI: 10.1002/mp.17492 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Physics, 2025. Verfasst von Anthony Bonfrate und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institut Curie, PSL Research University, Radiation Oncology Department, Proton Therapy Centre, Centre Universitaire, Orsay, France. Hauptthemen laut MEDLINE: Monte Carlo Method, Electrons, Radiotherapy, High-Energy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: GENCI, Grand Équipement National De Calcul Intensif.
Abstract (Originalsprache)
Background
Ultra‐high dose rate (UHDR/FLASH) irradiations, along with particle minibeam therapy (PMBT) are both emerging as promising alternatives to current radiotherapy techniques thanks to their improved healthy tissue sparing and similar tumor control.
Purpose
Monte Carlo (MC) modeling of a commercial machine delivering 5–7 MeV electrons at UHDR. This model was used afterward to compare measurements against simulations for an experimental setup combining both FLASH and PMBT modalities.
Methods
We modeled the main accelerator elements with TOPAS3.8/Geant4.10.07.p03, optimized the electron source parameters, and subsequently benchmarked this geometry against measurements. Minibeam experiments were performed by delivering 7 MeV electrons at UHDR on three different 65‐mm thick brass collimators as manufactured for protons with a 400‐µm slit width: single slit, 5 slits with a center‐to‐center (CTC) distance of 4 mm and 9 slits with CTC of 2 mm. Finally, complementary simulations were run by changing critical PMBT collimator parameters to assess their specific impact on peak‐to‐valley dose ratio (PVDR) as well as on the Bremsstrahlung photon contribution to the total dose.
Results
Percentage depth dose (PDD) distributions and lateral dose profiles showed a good agreement between simulations and measurements, with a maximum discrepancy of less than 4%. With the PMBT collimators in place, discrepancies between simulated and measured dose profiles, lateral and in‐depth in peaks and valleys, were within 3%. High PVDR between 5 and 26 were observed until 4 mm in the phantom. During the experiments, a mean dose rate of 167 Gy/s and an instantaneous dose rate of 1.2 × 10 5 Gy/s were obtained for the FLASH‐minibeam setup. PMBT collimator parameters need to be optimized to maximize PVDR while limiting Bremsstrahlung photon contribution to the total dose.
Conclusions
The validation of the MC model and the configuration of an electron FLASH‐minibeam setup were successfully completed, paving the way for future radiobiological investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institut Curie, PSL Research University, Radiation Oncology Department, Proton Therapy Centre, Centre Universitaire, Orsay, France.
- Institut Curie, PSL Research University, Inserm LITO, U1288, University of Paris Saclay, Orsay, France.
- Institut Curie - Research Center, U1021, Orsay, France.
Förderung
- GENCI
- Grand Équipement National De Calcul Intensif
Zitieren
APA
Bonfrate, A., Ronga, M. G., Patriarca, A., Heinrich, S., & De Marzi, L. (2025). Monte Carlo modeling of a commercial machine and experimental setup for FLASH‐minibeam irradiations with electrons. Medical Physics. https://doi.org/10.1002/mp.17492
Vancouver
Bonfrate A, Ronga MG, Patriarca A, Heinrich S, De Marzi L. Monte Carlo modeling of a commercial machine and experimental setup for FLASH‐minibeam irradiations with electrons. Medical Physics. 2025. doi:10.1002/mp.17492
BibTeX
@article{Bonfrate2025,
author = {Bonfrate, Anthony and Ronga, Maria Grazia and Patriarca, Annalisa and Heinrich, Sophie and De Marzi, Ludovic},
title = {Monte Carlo modeling of a commercial machine and experimental setup for FLASH‐minibeam irradiations with electrons},
journal = {Medical Physics},
year = {2025},
doi = {10.1002/mp.17492}
}
EUVIMED